Bayesian Capital Management, LP Quest Diagnostics Inc Transaction History

Bayesian Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$125.91 - $144.34 $1.11 Million - $1.27 Million	8,800 New	8,800 $1.2 Million
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $636,649 - $811,933	5,163 Added 211.86%	7,600 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$121.77 - $141.1 $52,848 - $61,237	-434 Reduced 15.12%	2,437 $299,000
Q2 2022 Aug 15, 2022	BUY	$127.07 - $145.39 $364,817 - $417,414	2,871 New	2,871 $382,000
Q4 2021 Feb 14, 2022	SELL	$140.36 - $173.01 $224,576 - $276,816	-1,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.95 - $158.0 $212,719 - $252,800	1,600 New	1,600 $232,000
Q4 2020 Feb 12, 2021	SELL	$112.7 - $128.05 $1.52 Million - $1.72 Million	-13,463 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$107.05 - $130.01 $1.09 Million - $1.32 Million	10,163 Added 307.97%	13,463 $1.54 Million
Q2 2020 Aug 14, 2020	BUY	$73.34 - $122.61 $242,022 - $404,613	3,300 New	3,300 $376,000
Q1 2020 May 15, 2020	SELL	$75.14 - $115.68 $668,746 - $1.03 Million	-8,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$100.29 - $107.99 $220,638 - $237,578	2,200 Added 32.84%	8,900 $950,000
Q3 2019 Nov 13, 2019	BUY	$97.85 - $107.42 $655,595 - $719,714	6,700 New	6,700 $717,000

923

95M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.